Brian L Davis
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brian L Davis.
Bioorganic & Medicinal Chemistry | 1994
Ramesh N. Patel; Amit Banerjee; Brian L Davis; Jeffrey M. Howell; Clyde G. McNamee; David Brzozowaski; Jeffrey T. North; David R. Kronenthal; Laszlo J. Szarka
The chiral intermediate (3S,4R)-trans-3,4-dihydro-3,4-dihydroxy-2,2-dimethyl- 2H-1-benzopyran-6-carbonitrile [(+)-trans diol 3] was made by the stereoselective microbial epoxidation of 2,2-dimethyl-2H-1-benzopyran-6-carbonitrile 1. This compound is a potential intermediate for the total synthesis of potassium-channel openers. Several microbial cultures were found which catalyzed the transformation of 1 to the corresponding (3S,4S)-epoxide 2 and (+)-trans diol 3. The two best cultures, Corynebacterium sp. SC 13876 and Mortierella ramanniana SC 13840 gave reaction yields of 32 M% and 67.5 M% and optical purities of 88 and 96%, respectively, for (+)-trans diol 3. A single-stage process (fermentation-epoxidation) for the biotransformation of 1 was developed using Corynebacterium sp. SC 13876 and M. ramanniana SC 13840. In a 25-L fermentor, the (+)-trans diol 3 was obtained in 38.6 M% yield with an optical purity of 90% using Corynebacterium SC 13876. The reaction yield of 60.7 M% and optical purity of 92.5% were obtained for (+)-trans diol 3 using M. ramanniana SC 13840. A two-stage process for the preparation of (+)-trans diol 3 was also developed using a 3 L cell-suspension (10% w/v, wet cells) of M. ramanniana SC 13840. The reaction was carried out in a 5-L Bioflo fermentor. The concentration of substrate 1 was 2 g L-1 with glucose present at 10 g L-1. After 48 h, (+)-trans diol 3 was obtained in 76 M% yield with an optical purity of 96%.(ABSTRACT TRUNCATED AT 250 WORDS)
Biotechnology and Applied Biochemistry | 2009
Brian L Davis; Mark Liu; Ronald L. Hanson; William L. Parker; Ramesh N. Patel
A total of 39 microbes were screened for the ability to selectively N‐demethylate (3R,5S,E)‐7‐(4‐(4‐fluorophenyl)‐6‐isopropyl‐2‐(methyl(1‐methyl‐1H‐1,2,4‐triazol‐5‐yl)aminopyrimidin‐5‐yl)‐3,5‐dihydroxy‐hept‐6‐enoic acid (I), a potential drug for lowering blood cholesterol levels. Two Streptomyces species were found to carry out the desired N‐demethylation. Bioconversion by Streptomyces griseus A.T.C.C. 13273 and product recovery were scaled up to the multi‐gram level.
Advanced Synthesis & Catalysis | 2008
Ronald L. Hanson; Brian L Davis; Yijun Chen; Steven L. Goldberg; William L. Parker; Michael A. Montana; Ramesh N. Patel
Organic Process Research & Development | 2008
Ronald L. Hanson; Brian L Davis; Steven L. Goldberg; Robert M. Johnston; William L. Parker; Michael A. Montana; Ramesh N. Patel
Archive | 2003
Samuel M. Babb; Lowell E. Kolb; Brian L Davis; Jonathan P Mankin; Kristina L Mann; Paul H Mazurkiewicz; Marvin Wahlen
Archive | 2003
Daniel A. Benigni; Robert Stankavage; Shu-Jen Chiang; Hsing Hou; Bruce Eagan; Dennis Gu; David Hou; Les Mintzmyer; Brian L Davis; Ivan Hargro; Mark Mascari; Gabriel Galvin; Gregory Stein; Cary W Mcconlogue; Fahri T Comezoglu
Archive | 1994
Brian L Davis; Paul M Cino; Laszlo J. Szarka
Archive | 2002
Samuel M. Babb; Brian L Davis; Lowell E. Kolb; Jonathan P Mankin; Kristina L Mann; Paul H Mazurkiewicz; Marvin Wahlen; クリスティナ・エル・マン; サミュエル・エム・バブ; ジョナサン・ピー・マンキン; ブライアン・エル・デイビス; ポール・エイチ・マズキーウィック; マービン・ウォーレン; ロウェル・イー・コルブ
Archive | 2008
Brian L Davis; Animesh Goswami; Ronald L. Hanson; William L. Parker; Ramesh N. Patel
Archive | 2003
Daniel A. Benigni; Brian L Davis